A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination
Yash Kripalani, Vidyadhara Lakkappan, Lipeeka Parulekar, Anjum Shaikh, Rakesh K. Singh, P. Vyas
Abstract
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition. LEARNING POINTS: Guillain-Barré Syndrome (GBS) is a very rare complication after vaccination against SARS-CoV-2.The key concepts related to the understanding, management and outcomes of patients with GBS are discussed.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Guillain-Barre syndromeVaccination2019-20 coronavirus outbreakPediatricsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyOutbreakInternal medicineDiseaseInfectious disease (medical specialty)Peripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19